Skip to main content
. 2010 Apr 18;2010:351908. doi: 10.1155/2010/351908

Figure 12.

Figure 12

Figure 12

Clinical course of a case with recurrent malignant glioma with bevacizumab and CPT11 treatment. After 3 cycles enhanced tumor and perifocal edema is markedly diminished (Bev 2 m). However, after 6 cycles T2 high intense tumors regrow with minimal enhancement (Bev 4 m).